|
COMPLETED
|
| 1 |
Hashim, S |
1994 |
Modulation of carcinogenesis in F1 progeny by translactionally delivered xenobiotic chemicals in mice |
Scientific reviewer, Health Canada, Ottawa, Canada |
| 2 |
Mukhopadhyay, R. |
1995 |
Polyamine biosynthetic pathway: a potential target for chemotherapy in Leishmania donovani |
Assoc. Prof. .Florida, Int. Univ.. USA |
| 3 |
Ghosh, A. |
1997 |
Expression and characterization of 2 open reading frames from LD1 locus of Leishmania donovani |
Senior Scientist, Atlantic Cancer Research Institute, Moncton, Canada |
| 4 |
Das,B. |
1998 |
Mechanism of chemomodulation of mammary carcinogenesis |
Scientist D, National Institute of Occupational Health, Gujarat |
| 5 |
Dole, V.S. |
1998 |
Biopterin transporter of Leishmania, genomic characterization and clinical relevance |
Senior Scientist, Harvard School of Medical Affiliate, USA |
| 6 |
Kapoor, P. |
1998 |
Leishmaniasis: Functional characterization of a novel biochemical with an aim to develop a better chemotherapeutic startegy |
R&D Head Lonza India · Lonza Knowledge Center |
| 7 |
Sidhu, A.B.S |
2000 |
Cloning and characterization of Plasmodium falciparum ornithine decarboxylase gene |
Senior Post Doc. Albert Einstein medical college, USA |
| 8 |
Sukumaran, B. |
2003 |
Functional characterization of ORF F from LD1 locus of Leishmania donovani |
Assistant Professor, Duke-NUS Graduate School |
| 9 |
Balaraman, S. |
2004 |
Signal transduction mechanism in macrophages upon infection by Leishmania donovani |
----------------------------------- |
| 10 |
Tewary, P. |
2005 |
Role of immunostimulatory oligodeoxynucleotides and leishmanial antigens in conferring protective immunity in mice infected with Leishmania donovani |
Scientist, Leido’s BioMed, USA |
| 11 |
Parasad K. Padmanabhan |
2006 |
A novel glyoxylase pathway in Leishmania donovani |
Research Fellow, Harvard School of Public Health, USA |
| 12 |
Angana Mukherjee |
2006 |
The molecular basis of drug resistance in Leishmania |
Research Associate, Harvard School of Public Health, USA |
| 13 |
Manju Jain |
2008 |
Functional characterization of amastigote specific genes of Leishmania donovani |
Assiastant Professor, Jaypee University, Solan (India) |
| 14 |
Sushma Singh |
2008 |
Alteration of Macrophages Gene Expression during Leishmania donovani infection |
Assistant Professor, NIPER, Mohali (India) |
| 15 |
Vandana K. Singh (Co-Supervisor/JNU) |
2008 |
Alteration of Macrophages Gene Expression during Leishmania donovani infection |
Assistant Professor, Hansraj College, Delhi University, India |
| 16 |
Mahendra Mahajan |
2010 |
Characterization of heat shock protein (HSP70) and other drug-resistance markers in Leishmania donovani |
Associate Professor, Tribhuvan University, Kathmandu, Nepal |
| 17 |
Ankur Sharma (Co-Supervisor/Gurukul Kangri) |
2010 |
Study of protective efficacy of an Oral DNA vaccine and an ubiquinated DNA vaccine against Visceral Leishmaniasis |
Post-doctoral Fellow, NIH, Bethesda,USA |
| 18 |
Anupam Jhingran |
2010 |
Modes of action and mechanisms of resistance to Paromomycin in Visceral Leishmaniasis |
Research Associate, Memorial Sloan Kettering Cancer Center, USA |
| 19 |
Swati Chattopadhyay (Co-Supervisor/University of Kolkata) |
2010 |
Detoxification of Methylglyoxal in Leishmania donovani |
Post-doctoral Fellow, Cancer Center, UNM,USA |
| 20 |
Swati Dadhich |
2010 |
Characterization of Visceral (VL) and Post kala-azar dermal Leishmaniasis (PKDL) isolates |
Post-doctoral Fellow, NIH, Bethesda,USA |
| 21 |
Bhawna Chawla |
2011 |
Hypusine Biosynthetic Pathway as a Potential Drug Target in Leishmania donovani |
Post-doctoral Fellow, FDA,USA |
| 22 |
Jyotsna Mishra (Co-Supervisor/AIIMS) |
2012 |
Elucidating the expression profile of the genes involved in apoptosis of Leishmania donovaniand their possible role in miltefosine resistance |
Post-doctoral Fellow, Thomas Jefferson University, USA |
| 23 |
Neha Biyani |
2012 |
Identification of potential drug targets and resistance mechanisms in Leishmania |
Post doctoral Fellow, USA |
| 24 |
Bhavana S. Lakshmi |
2014 |
Reverse Vaccinology Approach for Identification of Novel Vaccine candidates against Leishmania donovani |
----------------------------------- |
| 25 |
Alok K. Singh |
2015 |
Modulation of host cell interactomics by intracellular pathogen Leishmania donovani |
Post-doctoral Fellow at Johns Hopkins University, USA |
| 26 |
Sneha Anand |
2016 |
Identification and characterization of potential vaccine candidates against Leishmania donovani |
Post-doctoral Fellow, UK |
| 27 |
Reetika Manhas |
2016 |
Aminoacyl tRNA synthetases of Leishmania donovani as potential drug targets |
----------------------------------- |
| 28 |
Sanya Chadha Co-Supervisor:Dr. Gaurinath |
2019 |
Characterization and genetic validation of Aminoacyl tRNA synthetases in Leishmania donovani |
Post-doctoral Fellow, IMTECH, Chandigargh |
| 29 |
Ruby Bansal Co-Supervisor:Dr. Rohini Muthuswami |
2014 |
A plant like Cytochrome P450 subfamily CYP710A gene as a novel drug target in Leishmania donovani |
Junior Research Fellow, SLS, JNU |
| 30 |
Smriti Tandon Co-Supervisor:Dr. Gaurinath |
2015 |
Editing domains of aminoacyl-tRNA synthetases of Leishmania donovani |
Junior Research Fellow, SLS, JNU |
| 31 |
Har Simran Co-Supervisor:Dr. Rohini Muthuswami |
2016 |
Identification of Novel Epigenetic Regulators in Leishmania donovani and its Mammalian Host |
Junior Research Fellow, SLS, JNU |
